Search
Imitrodast
go.drugbank.com/drugs/DB20840ExperimentalImitrodast is a small molecule drug. The usage of the INN stem '-trodast' in the name indicates that Imitrodast is a antiasthmatic thromboxane A2-receptor antagonist. … Imitrodast has a monoisotopic molecular weight of 260.06 Da.
Tianafac
go.drugbank.com/drugs/DB21045ExperimentalTianafac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tianafac is a anti-inflammatory agent, ibufenac derivative. … Tianafac has a monoisotopic molecular weight of 240.0 Da.
Fenclofenac
go.drugbank.com/drugs/DB21391ExperimentalFenclofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Fenclofenac is a anti-inflammatory agent, ibufenac derivative. … Fenclofenac has a monoisotopic molecular weight of 296.0 Da.
Tifurac
go.drugbank.com/drugs/DB21415ExperimentalTifurac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative. … Tifurac has a monoisotopic molecular weight of 326.06 Da.
beta-Hydroxybutyric acid
go.drugbank.com/drugs/DB16506InvestigationalBeta-hydroxybutyrate is being studied in around 230 clinical trials, including NCT06351124 (recruiting for Crohn's disease), NCT05584371 (recruiting for safety and tolerability of exogenous ketosis), NCT04656236 (completed for type 1 dia...
EGEN-001
go.drugbank.com/drugs/DB05953InvestigationalEGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity
Tezacitabine
go.drugbank.com/drugs/DB06433InvestigationalA synthetic purine nucleoside analogue with potential antineoplastic activity.
CR002
go.drugbank.com/drugs/DB05139InvestigationalCR002 is a novel investigational fully human monoclonal antibody that blocks the activity of excess platelet-derived growth factor-D (PDGF-D), a target shown to play a role in kidney inflammation. … This is a novel therapeutic approach to treat kidney inflammation.
PRO-542
go.drugbank.com/drugs/DB05793InvestigationalPRO 542 belongs to a new class of drugs, viral-entry inhibitor, which is intended to prevent HIV from entering and infecting cells. … PRO 542 (CD4-immunoglobulin G2) is a tetravalent CD4-immunoglobulin fusion protein that broadly neutralizes primary HIV-1 isolates.